PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency

Clinical trial NCT06302439 · RECRUITING

Trial details

NCT number: NCT06302439
Sponsor: Inozyme Pharma
Status: RECRUITING
Study type: OBSERVATIONAL

Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency ATP-Binding Cassette Subfamily C Member 6 Deficiency

Start date: 2024-07-25
Primary completion: 2034-05-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.